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Received December 9, 2011; accepted March 9, 2012AbstractBackground: This study was conducted to investigate whether detectable missed breast cancers could be distinguished from truly false negative
images in a mammographic screening by a regular peer auditing.
Methods: Between 2004 and 2007, a total of 311,193 free nationwide biennial mammographic screenings were performed for 50- to 69-year-old
women in Taiwan. Retrospectively comparing the records in Taiwan’s Cancer registry, 1283 cancers were detected (4.1 per 1000). Of the total,
176 (0.6 per 1000) initial mammographic negative assessments were reported to have cancers (128 traditional films and 48 laser-printed digital
images). We selected 186 true negative films (138 traditional films and 48 laser-printed ones) as control group. These were seeded into 4815
films of 2008 images to be audited in 2009. Thirty-four auditors interpreted all the films in a single-blind, randomized, pair-control study. The
performance of 34 auditors was analyzed by chi-square test. A p value of <0.05 was considered significant.
Results: Eight (6 traditional and 2 digital films) of the 176 false negative films were not reported by the auditors (missing rate of 4.5%). Of this
total, 87 false negatives were reassessed as positive, while 29 of the 186 true negatives were reassessed as positive, making the overall
performance of the 34 auditors in interpreting the false negatives and true negatives a specificity of 84.4% and sensitivity of 51.8%. The
specificity and sensitivity in traditional films and laser-printed films were 98.6% versus 43.8% and 41.8% versus 78.3%, respectively. Almost
42% of the traditional false negative films had positive reassessment by the auditors, showing a significant difference from the initial screeners
( p < 0.001). The specificity of their reinterpretation of laser-printed films was obviously low.
Conclusion: Almost 42% of the false negative traditional films were judged as missed cancers in this study. A peer auditing should reduce the
probability of missed cancers.
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Early detection with screening mammography has the
potential to reduce breast cancer mortality rates.1,2 To quantify
the success of mammography screening in detecting early
breast cancer, the mammographic medical audit is recognizedhinese Medical Association. All rights reserved.
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Large-scale audits are normally conducted by governments,5
which have the financial and human resources to organize
a structured body for overseeing the audit, segregating the
diagnosis from screening data,6 and identifying false negative
cases,7 so that we can set standards for evaluation, including
the choice of hospitals, machines, screeners, and the content,
frequency, and type of continuing education required for
radiologists.8 The study of false negative reports contributes
greatly to the evaluation of screeners’ ability to recognize
signs of early breast cancer and the choice of images for
continuing education purposes.3,4 However, this approach
requires considering the threshold and subthreshold features of
malignancy.4 If only false negative cases are used to empha-
size the occult or subtle nonspecific mammographic findings,
this might increase the number of false positive cases, an
undesirable tradeoff.
Since 2002, Taiwan has provided free biennial mammog-
raphy screening for its entire population of women between 50
and 69 years old. It was not until 2004 that the number of
participants had increased to the extent that a large sample of
films could be studied. Thus, Taiwan’s Bureau of Health
Promotion has sponsored a retrospective annual audit of the
previous year’s mammography screening. As immediate audits
to confirm the readings are impossible, and positive results
(the diagnoses of breast cancer) may be delayed for 2 years
when they have been recorded on Taiwan’s Cancer Registry,
and not only the screeners but also the auditing program need
evaluation, thereafter, we conducted a single-blind, random-
ized, and pair-control study to evaluate the auditing program
and identify the detectable but misinterpreted false negatives.
2. Methods
Data on participants in a population-based mammography-
screening program were obtained from the Bureau of Health
Promotion, which coordinates cancer screening in Taiwan.
Each patient receives a standard screening examination con-
sisting of a mediolateral oblique view and a craniocaudal view
of each breast. To be qualified to interpret the mammograms,
all screeners (board-certified radiologists with specific training
in screening mammography) are required to have interpreted
at least 1000 mammograms previously. Each screening
mammogram is categorized using the Breast Imaging
Reporting and Data System (BI-RADS) derived from the
American College of Radiology criteria. When there is more
than one lesion in a breast, only the highest BI-RADS
assessment category is recorded. In addition to lesion cate-
gory, screeners’ reports also include breast density and specific
recommendations for each case. Mammograms assessed as BI-
RADS 1, 2, or 3 are defined as negative, while those assessed
as BI-RADS 0 (needs additional examination), 4, or 5 are
defined as positive.
Our annual auditing design, instead of conducting a full
audit, mainly focuses on the assessments of initial screeners
who perform below benchmark. According to the stipulation
of the Taiwan’s Bureau of Health Promotion, if the initialscreener’s recall rate is higher than 20%, the selection will
focus on positive assessment to find out avoidable false posi-
tive assessments; if the initial screener’s recall rate is less than
7%, the selection will focus on negative assessment to avoid
false negative. The audited films are randomly submitted to
the 34 auditors. To be auditors, they must have a minimum
experience of 5 years, each having interpreted more than 3000
screening mammograms and each rated within the top 25%
most accurate readers.
Between 2004 and 2007, there were 311,193 consecutive
screenings performed by 230 qualified radiologists, with 1283
cancers detected (4.1 per 1000), while 176 patients (0.57 per
1000) with initial mammographic negative assessments were
reported to have cancers in Taiwan’s Cancer Registry within
the following 12 months. The latter were categorized as false
negatives. These consisted of 128 traditional films (74 BI-
RADS 1, 38 BI-RADS 2, and 16 BI-RADS 3) and 48 laser-
printed digital images (19 BI-RADS 1; 19 BI-RADS 2; 10
BI-RADS 3). We created two BI-RADS-matched control
groups, one using 138 true negative traditional films and the
other 48 true negative laser-printed digital images; all of them
were not reported to have cancers on the Cancer Registry for
at least the following 3 years. The false negative study groups
(n ¼ 176) and control groups (n ¼ 186) were then seeded
within the 4815 mammograms of 2008 slated to be audited in
2009. The 48 false negative laser-printed films were further
reread by three specialists with mammographic experience of
more than 10 years with consensus to analyze the imaging
features of the undetectable or missed cancers.
All demographic information belonging to the screened
women was anonymized and replaced with dummy values to
protect healthcare information. The protocol for this study was
approved by the institutional review board at Kaohsiung
Veterans General Hospital, and the study was performed
according to the principles set forth in the Declaration of
Helsinki.
The performance of the 34 auditors was analyzed by chi-
square test. A p value <0.05 was considered significant. All
statistical operations were performed using SPSS version 12.0.
3. Results
Of the 2008 audited films, 75 mammographic films were
not responded by the auditors (miss rate of 1.5%). With regard
to the 176 seeded false negative study films, six traditional and
two laser-printed digital images were not responded (missing
rate of 4.5%), leaving us with 168 study films to include in our
analysis. Of this total, 87 false negative study films (51.8%)
were assessed as positive by the auditors (Table 1), repre-
senting a detection rate of 4.4 per 1000 [(1283 þ 87)/311,193]
if the missed cancers were added. Meanwhile, 29 (15.6%) of
the 186 true negative (control) images were assessed as
positive, suggesting a significant difference in assessments by
the auditors and those by the screeners ( p < 0.001).
If the traditional and laser-printed digital study films were
analyzed separately, we could find different performance of
the auditors between the two films. For the traditional images,
Table 1
The overall performance of auditors in interpretation of false negative (FN)
and true negative (TN).
Number of pos-
by auditors (%)
Number of neg-
by auditors (%)
Total
FN 87 (51.8) 81 (48.2) 168
TN 29 (15.6) 157 (84.4) 186
Total 116 (32.8) 238 (67.2) 354
p < 0.001, calculated by chi-square test.
Table 3
The performance of auditors in the interpretation of false negative and true
negative on laser printed digital films.
Number of pos-
by auditors (%)
Number of neg-
by auditors (%)
Total
FN 36 (78.3) 10 (21.7) 46
TN 27 (56.3) 21 (43.8) 48
Total 63 (67.0) 31 (33.0) 94
p ¼ 0.023, calculated by chi-square test.
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1.4% of 138 true negative cases reassessed as positive. The
sensitivity of the auditors’ assessment of traditional films was
41.8%, with 52.8% false negatives still unrecognized
(Table 2). The specificity and sensitivity of the auditors’
reassessments of the laser-printed digital images were 43.8%
and 78.3%, respectively (Table 3). The auditors’ ability to
interpret the laser-printed digital images showed less signifi-
cant difference ( p ¼ 0.023). They reinterpreted 56.3% of the
true negative films as positive, a much higher differential rate
than their reinterpretations of the non-study and non-control
group films, which was only 3.4%. As to the imaging
features of the 48 laser-printed false negative mammograms,
22 (46%) mammograms were considered unpredictable
because of dense breast tissue or with nonspecific mammo-
graphic sign to indicate malignancy, while 26 (54%) were
judged as missed cancers. Of the latter, 20 patients (77%) had
the breast density of extremely dense or heterogeneously
dense. The lesions were located in the right breast in 16
patients and in 10 in the left breast. Two lesions could be seen
in one view only. The mammographic findings in these 26
missed cancers include calcifications in 7 patients (27%), mass
or focal asymmetry in 19 (73%) with architectural distortion
found in four.4. Discussion
In clinical practice, there are two kinds of false negatives on
mammograms. The first is truly false negative, which is either
rapid-growth cancers that have become clinically evident
during a short-term follow-up or image-occult cancers that are
not visible mammographically (e.g., dense breast tissue or
machine limitation). The other false negative is the detectable
missed cancers that were present at the time of screening but
not recognized or misinterpreted by the screening radiolo-
gists.9 In this single-blind study, we defined missed cancers as
ones which could be recognized by auditors during the peerTable 2
The performance of auditors in interpretation of false negative and true
negative on traditional films.
Number of pos-
by auditors (%)
Number of neg-
by auditors (%)
Total
FN 51 (41.8) 71 (58.2) 122
TN 2 (1.4) 136 (98.6) 138
Total 53 (20.4) 207 (79.6) 260
p < 0.001, calculated by chi-square test.auditing review to distinguish truly false negative films
(undetectable cancers) from detectable missed cancers. Our
study showed that 51.8% of the false negatives, being reas-
sessed as positive by the auditors, were missed cancers. If the
missed cancers can be included, the cancer detection rate will
be 4.4 per 1000, making a 7.3% increase as compared with the
initial detection rate of 4.1 per 1000. The increase rate is
comparable to those reported (5e15%) in the literature.10
If only traditional films were taken into account, the truly
false negatives were even higher (58.2%). To avoid a “witch
hunt,” effect on the screeners which may increase large
number of false positives in later interpretation, the later
educational programs should focus on the characteristics of
avoidable missed cancers only. In this study, we did not
consider the auditors’ competence to be a major issue since
they had correctly reinterpreted most of the true negative
traditional films as negative (specificity: 98.6%), and there
found a significant difference between their assessments and
those of the initial screeners.
As to the laser-printed films, the auditors reassessed 78.3%
of 46 false negative films to be positive, but also 56.3% of the
48 true negatives to be positive, much higher than the rates
found in their reinterpretation of traditional ones. As the
diagnostic accuracy of digitized images was considered to be
equivalent to that of traditional screen-film mammograms,11
these findings suggested that something about the laser-
printed control films led the reviewers to sense they were
problematic, probably making the auditors more suspicious
and leading to what has been called intelligent failure.12 In
fact, the seeded laser-printed films did look different from the
other 4815 audited and 267 study/control traditional films,
which probably gave rise to some suspicion. This would
reduce the statistical power of differences in our analysis,
meaning that the interpretations of the auditors were not
completely objective, rendering the evaluation of the laser-
printed film unreliable. Thus, the detectable cancers in this
group cannot be utilized as teaching materials since that might
lead to a compromise of the false positive tradeoff.
In this review, the false negative rate of screening
mammography in Taiwan was 0.057%, which is comparable to
that of Siegal et al’s series (0.098%).13 As to the laser-printed
images reread by three specialists in our review, 54% of the
false negatives were interpreted as missed cancers, which is
slightly higher than that in Siegal et al’s series (39%). It may
be due to more dense breasts tissue in our patients (77% vs.
60%). The majority (73%) of findings of missed cancers were
asymmetries or masses, which is comparable to previous
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(27e30%) of the mammographically missed cancers. From
the peer review process, we can identify any radiologists who
may require additional training, and the mammographic
features of the missed cancers can be used for later education.
This study has several limitations. First, therewas the obvious
blinding problem in the reassessment of the laser-printed films,
as indicated by the statistics. Future such studies require devising
a more effective way of blinding for laser-printed images, since
their use is increasing nowadays. Second, a few reassessment
sheets from the study group and the control groupwere not filled
out, suggesting that the auditors may not have been able to make
a decision. Third, we did not perform analysis of the relationship
between pathology and mammogram findings. Further study to
gain better insight into what features might lead to missing
a detectable cancer is warranted.
In conclusion, we found a significant difference in the initial
assessments of the screeners and the reassessments of the
auditors, especially in the traditional films. The false negative
films reassessed as positive by the auditors can be used for future
continuing education courses for radiologists, especially if the
factors leading to their miss can be identified. The false negative
cases with cancers missed by both screeners and auditors cannot
be used for training, as they are truly undetectable. The results of
this study confirmed that the peer auditing design was able to
reduce the false negative rate and improve our national
screening program. We hope that this study might lead to
implementation of such national screening programs for breast
cancer in other countries, and if they already have such
programs in place, then improvement of those programs.
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